What's in BicycleTx Limited's pipeline?

BicycleTx Limited has 3 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with BicycleTx Limited's portfolio?

Top competitors by shared drug class: Gustave Roussy, Cancer Campus, Grand Paris, Jiangsu HengRui Medicine Co., Ltd., Kuhnil Pharmaceutical Co., Ltd., Merck KGaA, Darmstadt, Germany, Pharmicell Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bicycletx-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

BicycleTx Limited — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BicycleTx Limited pipeline: 0 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Gustave Roussy, Cancer Campus, Grand Paris · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
Kuhnil Pharmaceutical Co., Ltd. · 1 shared drug class
Merck KGaA, Darmstadt, Germany · 1 shared drug class
Pharmicell Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for BicycleTx Limited:

Cite this brief

Drug Landscape (2026). BicycleTx Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bicycletx-limited. Accessed 2026-06-10.